FAST NEWS: Shanghai Junshi Biosciences Expects its 2021 Loss to Narrow
The latest: Shanghai Junshi Biosciences Co., Ltd. (1877.HK, 688180.SH) announced its 2021 results forecast late Friday, estimating its net loss would be 736 million yuan ($115.7 million), narrowing from 933…
RELATED ARTICLES
-
Junshi hopes new scientist CEO can cure its woes
1877.HK 688180.SHG -
Junshi narrows its losses but delivers no cure for share price woes
1877.HK 688180.SHG
- Lopal Tech seeks cash after losses balloon with lithium price plunge
- Increasing losses prompt Zephyrm Bioscience to seek funds through IPO
- Payment app Lianlian seeks IPO relief from cash crunch
-
Jinko sees sunnier skies in Germany with new fundraising plan
JKS.US 688223.SHG
